The Australian share market finished session at fresh 11-month high on Monday, 25 January 2021, as investor sentiment received a boost following news that the Pfizer/BioNTech COVID-19 vaccine has been approved for use in Australia, with the phased vaccine rollout set to commence in late February.
At closing bell, the benchmark S&P/ASX200 advanced 24.35 points, or 0.36%, to 6,824.71. The broader All Ordinaries added 32.45 points, or 0.46%, to 7,111.39. Australian share market will be close tomorrow for Australia Day public holiday.
Investor sentiment received a boost following news that the Pfizer/BioNTech COVID-19 vaccine has been approved for use in Australia, with the phased vaccine rollout set to commence in late February.
With the exception of energy stocks, gold miners and travels stocks within the industrial sector, all other areas of the market finished higher.
Travel stocks underperformed, with both Webjet (WEB) and Flight Centre (FLT) slumping by 3%. These stocks lost ground despite no new COVID cases across most of the country and the Pfizer vaccine receiving a nod of approval for distribution in Australia starting next month.
Ampol (ALD) was the worst performer on the ASX 200, slipping by 4.9% after completing its $300m off-market share-buyback at a discounted price.
Lynas (LYC) slumped by 3.2% a day after surging close to 14%. The rare earths miner on Friday said it had reached a deal with the US Department of Defence to build a facility in Texas.
CURRENCY NEWS: The Australian dollar changed hands at $0.773, off levels above $0.776 seen last week.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU